Good questions.
My view, it will be very difficult using current data. But, if they have success in the Covid-ARDS trial, both issues (stock & consistency) will be addressed. Stock will be consumed and MSB will have more data to support their measurements for batch consistency and in turn the measurements link to efficacy. If efficacy is shown for ARDS, the FDA will work with them post approval of Ryoncil on batch consistency measurements IMO. We should know by year end, and who can't wait for 2020 to end!!
cheers
- Forums
- ASX - By Stock
- MSB
- Ann: Update on BLA for Graft Versus Host Disease
Ann: Update on BLA for Graft Versus Host Disease, page-349
-
- There are more pages in this discussion • 207 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
92.5¢ |
Change
-0.020(2.12%) |
Mkt cap ! $1.050B |
Open | High | Low | Value | Volume |
93.0¢ | 93.5¢ | 92.0¢ | $2.103M | 2.270M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 106422 | 92.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
93.0¢ | 59027 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 513 | 0.975 |
3 | 11596 | 0.970 |
1 | 283 | 0.960 |
6 | 1850 | 0.945 |
2 | 12841 | 0.940 |
Price($) | Vol. | No. |
---|---|---|
0.845 | 1000 | 1 |
0.875 | 3046 | 2 |
0.880 | 2745 | 3 |
0.890 | 11080 | 2 |
0.900 | 54209 | 13 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |